FR2959227B1 - Nano-objets magneto-optiques pour la detection des cancers - Google Patents

Nano-objets magneto-optiques pour la detection des cancers

Info

Publication number
FR2959227B1
FR2959227B1 FR1053139A FR1053139A FR2959227B1 FR 2959227 B1 FR2959227 B1 FR 2959227B1 FR 1053139 A FR1053139 A FR 1053139A FR 1053139 A FR1053139 A FR 1053139A FR 2959227 B1 FR2959227 B1 FR 2959227B1
Authority
FR
France
Prior art keywords
magneto
objects
cancer detection
optical nano
nano
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1053139A
Other languages
English (en)
Other versions
FR2959227A1 (fr
Inventor
Genevieve Pourroy
Sylvie Begin-Colin
Delphine Felder-Flesch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1053139A priority Critical patent/FR2959227B1/fr
Priority to PCT/FR2011/050914 priority patent/WO2011131912A1/fr
Publication of FR2959227A1 publication Critical patent/FR2959227A1/fr
Application granted granted Critical
Publication of FR2959227B1 publication Critical patent/FR2959227B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3882—Arylalkanephosphonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B11/00—Diaryl- or thriarylmethane dyes
    • C09B11/04—Diaryl- or thriarylmethane dyes derived from triarylmethanes, i.e. central C-atom is substituted by amino, cyano, alkyl
    • C09B11/10—Amino derivatives of triarylmethanes
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B69/00—Dyes not provided for by a single group of this subclass
    • C09B69/10—Polymeric dyes; Reaction products of dyes with monomers or with macromolecular compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR1053139A 2010-04-23 2010-04-23 Nano-objets magneto-optiques pour la detection des cancers Expired - Fee Related FR2959227B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1053139A FR2959227B1 (fr) 2010-04-23 2010-04-23 Nano-objets magneto-optiques pour la detection des cancers
PCT/FR2011/050914 WO2011131912A1 (fr) 2010-04-23 2011-04-20 Nano-objets magneto-optiques pour la detection des cancers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1053139A FR2959227B1 (fr) 2010-04-23 2010-04-23 Nano-objets magneto-optiques pour la detection des cancers

Publications (2)

Publication Number Publication Date
FR2959227A1 FR2959227A1 (fr) 2011-10-28
FR2959227B1 true FR2959227B1 (fr) 2012-06-22

Family

ID=43303963

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1053139A Expired - Fee Related FR2959227B1 (fr) 2010-04-23 2010-04-23 Nano-objets magneto-optiques pour la detection des cancers

Country Status (2)

Country Link
FR (1) FR2959227B1 (fr)
WO (1) WO2011131912A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9623127B2 (en) 2011-11-18 2017-04-18 Centre National De La Recherche Scientifique Multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging
WO2015150502A1 (fr) * 2014-04-01 2015-10-08 Centre National De La Recherche Scientifique Nanoparticules d'oxyde métallique dendronisé, leur procédé de préparation et leurs utilisations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823092B1 (fr) 2001-04-10 2004-03-05 Eurorad 2 6 Dispositif per-operatoire pour la localisation de tissus marques et procede utilisant un tel dispositif
FR2906806B1 (fr) * 2006-10-09 2012-12-14 Centre Nat Rech Scient Complexes chelates dendritiques, leurs procedes de fabrication et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
FR2959227A1 (fr) 2011-10-28
WO2011131912A1 (fr) 2011-10-27

Similar Documents

Publication Publication Date Title
HK1252832A1 (zh) 用於治療結腸直腸癌的方法
EP2585833A4 (fr) Procédés de détection de cancer
EP2659005A4 (fr) Profilage moléculaire pour le cancer
IL239147B (en) Determining a molecular profile for cancer
EP2718485A4 (fr) Profilage moléculaire pour le cancer
PT2829881T (pt) Diagnóstico para cancro colo-rectal
IL224370B (en) Combination treatment for prostate carcinoma
GB201302520D0 (en) Compositions and methods for detecting cancer metastasis
EP2438197A4 (fr) Procédé de détection du cancer
GB201016139D0 (en) Cancer phosholipidome
EP2524233A4 (fr) Compositions et procédés pour la détection du cancer
EP2698634A4 (fr) Biomarqueur pour le cancer du sein
EP2648762A4 (fr) Pronostic du cancer du sein après traitement
EP2635286A4 (fr) Méthodes de traitement du cancer
PT2876447T (pt) Método para deteção de cancro
EP2657346A4 (fr) Procédé de détection d'une cellule cancéreuse
GB201012590D0 (en) Methods for diagnosing cancer
GB0820309D0 (en) Detection of cancer
PT2876446T (pt) Método para deteção de cancro
EP2433137A4 (fr) Procédés de détection de cancer du rein
EP2894477A4 (fr) Procédé de dépistage du cancer du sein
EP2735571A4 (fr) Anticorps pour un marqueur du cancer colorectal
FR2959227B1 (fr) Nano-objets magneto-optiques pour la detection des cancers
EP2594943A4 (fr) Procédé de détection d'une cellule tumorale maligne
EP2283148A4 (fr) Procédés cytologiques pour le dépistage du cancer

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20131231